المؤلفون: Bent S; Department of Psychiatry, University of California at San Francisco , San Francisco, CA., Ailarov A; Department of Psychiatry, University of California at San Francisco , San Francisco, CA., Dang KT; Department of Psychiatry, University of California at San Francisco , San Francisco, CA., Widjaja F; Department of Psychiatry, University of California at San Francisco , San Francisco, CA., Lawton BL; Department of Psychiatry, University of California at San Francisco , San Francisco, CA., Hendren RL; Department of Psychiatry, University of California at San Francisco , San Francisco, CA.

المصدر: Journal of alternative and complementary medicine (New York, N.Y.) [J Altern Complement Med] 2017 May; Vol. 23 (5), pp. 394-395. Date of Electronic Publication: 2017 Feb 16.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9508124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7708 (Electronic) Linking ISSN: 10755535 NLM ISO Abbreviation: J Altern Complement Med Subsets: MEDLINE

مواضيع طبية MeSH: Dietary Supplements*, Autism Spectrum Disorder/*drug therapy , Cholecalciferol/*therapeutic use, Autism Spectrum Disorder/physiopathology ; Child ; Child, Preschool ; Female ; Humans ; Randomized Controlled Trials as Topic ; Severity of Illness Index